Connection
Jane Reusch to Incretins
This is a "connection" page, showing publications Jane Reusch has written about Incretins.
|
|
Connection Strength |
|
|
|
|
|
0.278 |
|
|
|
-
Reusch JE, Manson JE. Management of Type 2 Diabetes in 2017: Getting to Goal. JAMA. 2017 03 14; 317(10):1015-1016.
Score: 0.151
-
Reusch J, Stewart MW, Perkins CM, Cirkel DT, Ye J, Perry CR, Reinhardt RR, Bode BW. Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without metformin. Diabetes Obes Metab. 2014 Dec; 16(12):1257-64.
Score: 0.127